| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a899eba0e35112cc25b4aa1b0b7fda90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03721e344a72026d125291e6c56c1be6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 |
| filingDate |
1991-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a94fce179ec740c826000538adf9670
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fab25414ed38a124a3facb43795b80a |
| publicationDate |
1998-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SK-279225-B6 |
| titleOfInvention |
PHARMACEUTICAL PRODUCT FOR SCHIZOFRÉ TREATMENT |
| abstract |
Pharmaceutical composition suitable for the treatment of schizophrenia consists of clozapine and L-ascorbic acid. Clozapine to L-ascorbic acid ratio ranges from 1 : 3 to 1 : 40 by weight. One dosage volume contains 25 milligrams or 100 milligrams of clozapine. |
| priorityDate |
1990-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |